nach oben

Erschienen in:

01.03.2008 | Review

Diffuse optical imaging of the healthy and diseased breast: A systematic review

verfasst von: Daniel Richard Leff, Oliver J. Warren, Louise C. Enfield, Adam Gibson, Thanos Athanasiou, Darren K. Patten, Jem Hebden, Guang Zhong Yang, Ara Darzi

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Screening X-ray mammography is limited by false positives and negatives leading to unnecessary physical and psychological morbidity. Diffuse Optical Imaging using harmless near infra red light, provides lesion detection based on functional abnormalities and represents a novel diagnostic arm that could complement traditional mammography. Reviews of optical breast imaging have not been systematic, are focused mainly on technological developments, and have become superseded by rapid technological advancement. The aim of this study is to review clinically orientated studies involving approximately 2,000 women in whom optical mammography has been used to evaluate the healthy or diseased breast. The results suggest that approximately 85% of breast lesions are detectable on optical mammography. Spectroscopic resolution of tissue haemoglobin composition and oxygen saturation may improve the detectability of breast diseases. Results suggest that breast lesions contain approximately twice the haemoglobin concentration of background tissue. Current evidence suggests that it is not possible to distinguish benign from malignant disease using optical imaging techniques in isolation. Methods to improve the performance of Diffuse Optical Imaging, such as better spectral coverage with additional wavelengths, improved modelling of light transport in tissues and the use of extrinsic dyes may augment lesion detection and characterisation. Future research should involve large clinical trials to determine the overall sensitivity and specificity of optical imaging techniques as well as to establish patient satisfaction and economic viability.

Breast cancer: incidence rises while death continues to fall. Available via http://www.statistics.gov.uk. Cited 4 Dec 2006

Tabar L, Yen MF, Vitak B et al (2003) Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 361:1405–1410PubMedCrossRef

Screening for breast cancer in England: past and future. Available via http://www.cancerscreening.nhs.uk/. Cited 4 Dec 2006

Huynh PT, Jarolimek AM, Daye S (1998) The false-negative mammogram. Radiographics 18:1137–1154PubMed

Elmore JG, Barton MB, Moceri VM et al (1998) Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 338:1089–1096PubMedCrossRef

Lucassen A Watson E, Eccles D (2004) Advice about mammography for a young woman with a family history of breast cancer. Br Med J 322:1040–1042CrossRef

Cutler M (1929) Transillumination of the breast. Surg Gynaecol Obstet 48:721–727

Arridge SR, Lionheart WRB (1998) Non-uniqueness in diffusion-based optical tomography. Opt Lett 23:882–884PubMed

Nissilä IHJ, Jennions D, Heino J et al (2006) Comparison between a time-domain and a frequency-domain system for optical tomography. J Biomed Opt 11:064015PubMedCrossRef

10.

Nioka S, Chance B (2005) NIR spectroscopic detection of breast cancer. Technol Cancer Res Treat 4:497–512PubMed

11.

Gibson AP, Hebden JC, Arridge SR (2005) Recent advances in diffuse optical imaging. Phys Med Biol 50:R1–R43PubMedCrossRef

12.

Hebden JC, Delpy DT (1997) Diagnostic imaging with light. Br J Radiol 70:S206–S214PubMed

13.

Arridge SR, Hebden JC (1997) Optical imaging in medicine: II. Modelling and reconstruction. Phys Med Biol 42:841–853PubMedCrossRef

14.

Ntziachristos V, Chance B (2001) Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Res 3:41–46PubMedCrossRef

15.

Spinelli L, Torricelli A, Pifferi A et al (2004) Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography. J Biomed Opt 9:1137–1142PubMedCrossRef

16.

Shah N, Cerussi A, Eker C et al (2001) Noninvasive functional optical spectroscopy of human breast tissue. PNAS 98:4420–4425PubMedCrossRef

17.

Shah N, Cerussi AE, Jakubowski D et al (2004) Spatial variations in optical and physiological properties of healthy breast tissue. J Biomed Opt 9:534–540PubMedCrossRef

18.

Pogue BW, Jiang S, Dehghani H et al (2004) Characterization of hemoglobin, water, and NIR scattering in breast tissue: analysis of intersubject variability and menstrual cycle changes. J Biomed Opt 9:541–552PubMedCrossRef

19.

Srinivasan S, Pogue BW, Brooksby B et al (2005) Near-infrared characterization of breast tumors in vivo using spectrally-constrained reconstruction. Technol Cancer Res Treat 4:513–526PubMed

20.

Srinivasan S, Pogue BW, Jiang S et al (2003) Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography. Proc Natl Acad Sci USA 100:12349–12354PubMedCrossRef

21.

Durduran T, Choe R, Culver JP et al (2002) Bulk optical properties of healthy female breast tissue. Phys Med Biol 47:2847–2861PubMedCrossRef

22.

Cerussi AE, Berger AJ, Bevilacqua F et al (2001) Sources of absorption and scattering contrast for near-infrared optical mammography. Acad Radiol 8:211–218PubMedCrossRef

23.

Simick MK, Jong R, Wilson B et al (2004) Non-ionizing near-infrared radiation transillumination spectroscopy for breast tissue density and assessment of breast cancer risk. J Biomed Opt 9:794–803PubMedCrossRef

24.

Pifferi A, Swartling J, Chikoidze E et al (2004) Spectroscopic time-resolved diffuse reflectance and transmittance measurements of the female breast at different interfiber distances. J Biomed Opt 9:1143–1151PubMedCrossRef

25.

Suzuki K Yamashita Y, Ohta K et al (1996) Quantitative measurements of optical parameters in normal breasts using time-resolved spectrsocopy: in vivo results of 30 Japanese women. J Biomed Opt 1:330–334CrossRef

26.

Spinelli L, Torricelli A, Pifferi A et al (2005) Characterization of female breast lesions from multi-wavelength time-resolved optical mammography. Phys Med Biol 50:2489–2502PubMedCrossRef

27.

Intes X (2005) Time-domain optical mammography SoftScan: initial results. Acad Radiol 12:934–947PubMedCrossRef

28.

Zhu Q, Cronin EB, Currier AA et al (2005) Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction. Radiology 237:57–66PubMedCrossRef

29.

Zhu Q, Kurtzma SH, Hegde P et al (2005) Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers. Neoplasia 7:263–270PubMedCrossRef

30.

Zhu Q, Huang M, Chen N et al (2003) Ultrasound-guided optical tomographic imaging of malignant and benign breast lesions: initial clinical results of 19 cases. Neoplasia 5:379–388PubMed

31.

Grosenick D, Moesta KT, Wabnitz H et al (2003) Time-domain optical mammography: initial clinical results on detection and characterization of breast tumors. Appl Opt 42:3170–3186PubMedCrossRef

32.

Grosenick D, Wabnitz H, Moesta KT et al (2004) Concentration and oxygen saturation of haemoglobin of 50 breast tumours determined by time-domain optical mammography. Phys Med Biol 49:1165–1181PubMedCrossRef

33.

Grosenick D, Moesta KT, Moller M et al (2005) Time-domain scanning optical mammography: I. Recording and assessment of mammograms of 154 patients. Phys Med Biol 50:2429–2449PubMedCrossRef

34.

Grosenick D, Wabnitz H, Moesta KT et al (2005) Time-domain scanning optical mammography: II. Optical properties and tissue parameters of 87 carcinomas. Phys Med Biol 50:2451–2468PubMedCrossRef

35.

Yates T, Hebden JC, Gibson AP et al (2005) Optical tomography of the breast using a multi-channel time-resolved imager. Phys Med Biol 50:2503–2517PubMedCrossRef

36.

Pogue BW, Poplack SP, McBride TO et al (2001) Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. Radiology 218:261–266PubMed

37.

Taroni P, Torricelli A, Spinelli L et al (2005) Time-resolved optical mammography between 637 and 985 nm: clinical study on the detection and identification of breast lesions. Phys Med Biol 50:2469–2488PubMedCrossRef

38.

Taroni P, Pifferi A, Torricelli A et al (2004) Do shorter wavelengths improve contrast in optical mammography? Phys Med Biol 49:1203–1215PubMedCrossRef

39.

Taroni P, Danesini G, Torricelli A et al (2004) Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm. J Biomed Opt 9:464–473PubMedCrossRef

40.

Chance B, Nioka S, Zhang J et al (2005) Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. Acad Radiol 12:925–933PubMedCrossRef

41.

Moesta KT, Fantini S, Jess H et al (1998) Contrast features of breast cancer in frequency-domain laser scanning mammography. J Biomed Opt 3:129–136CrossRef

42.

Gu X, Zhang Q, Bartlett M et al (2004) Differentiation of cysts from solid tumors in the breast with diffuse optical tomography. Acad Radiol 11:53–60PubMedCrossRef

43.

Durduran T, Choe R, Yu G et al (2005) Diffuse optical measurement of blood flow in breast tumors. Opt Lett 30:2915–2917PubMedCrossRef

44.

Cerussi AE, Jakubowski D, Shah N et al (2002) Spectroscopy enhances the information content of optical mammography. J Biomed Opt 7:60–71PubMedCrossRef

45.

Poplack SP, Paulsen KD, Hartov A et al (2004) Electromagnetic breast imaging: average tissue property values in women with negative clinical findings. Radiology 231:571–580PubMedCrossRef

46.

Fowler PA, Casey CE, Cameron GG et al (1990) Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging. Br J Obstet Gynaecol 97:595–602PubMed

47.

Graham SJ, Stanchev PL, Lloyd-Smith JO et al (1995) Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T. J Magn Reson Imaging 5:695–701PubMedCrossRef

48.

Byrne C, Schairer C, Wolfe J et al (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622–1629PubMedCrossRef

49.

van Gils CH, Otten JD, Hendriks J et al (1999) High mammographic breast density and its implications for the early detection of breast cancer. J Med Screen 6:200–204PubMed

50.

van Veen RL, Sterenborg HJ, Marinelli AW et al (2004) Intraoperatively assessed optical properties of malignant and healthy breast tissue u sed to determine the optimum wavelength of contrast for optical mammography. J Biomed Opt 9:1129–1136PubMedCrossRef

51.

Ntziachristos V, Yodh AG, Schnall MD et al (2002) MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 4:347–354PubMedCrossRef

52.

Hsiang D, Shah N, Yu H et al (2005) Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer. Technol Cancer Res Treat 4:549–558PubMed

53.

Potten CS, Watson RJ, Williams GT et al (1988) The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58:163–170PubMed

54.

Going JJ, Anderson TJ, Battersby S et al (1988) Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130:193–204PubMed

55.

Hutson SW, Cowen PN, Bird CC et al (1985) Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol 38:281–287PubMedCrossRef

56.

Mandelson MT, Oestreicher N, Porter PL et al (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081–1087PubMedCrossRef

57.

Rice A, Quinn CM (2002) Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast. J Clin Pathol 55:569–574PubMedCrossRef

58.

Folkman J (1995) The influence of angiogenesis research on management of patients with breast cancer. Breast Cancer Res Treat 36:109–118PubMedCrossRef

59.

Intes X, Ripoll J, Chen Y et al (2003) In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. Med Phys 30:1039–1047PubMedCrossRef

60.

Morris N, Hebden JC, Bland T et al (2003) Role of patient feedback in the design and implementation of clinical trials of optical tomography of the breast. In: Boas D (ed) Proceedings of SPIE, vol 5138: Photon migration and diffuse-light imaging. David Boas, Massachusetts General Hospital, pp 12–22

61.

Morris N, Balmer B (2006) Are you sitting comfortably? Perspectives of the researchers and the researched on ‘being comfortable’. Account Res 13:111–133PubMed

Titel: Diffuse optical imaging of the healthy and diseased breast: A systematic review
verfasst von: Daniel Richard Leff
Oliver J. Warren
Louise C. Enfield
Adam Gibson
Thanos Athanasiou
Darren K. Patten
Jem Hebden
Guang Zhong Yang
Ara Darzi
Publikationsdatum: 01.03.2008
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 1/2008
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-007-9582-z

Springer Medizin

Diffuse optical imaging of the healthy and diseased breast: A systematic review

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2008

A Phase 2 study of perifosine in advanced or metastatic breast cancer

Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control

Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer

A phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy

Evaluation of radiolabeled bombesin analogs in animals

Controversies in preservation of ovary function and fertility in patients with breast cancer

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie